docetaxel anhydrous has been researched along with Chronic Lung Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, T; Akahori, D; Hasegawa, H; Koda, K; Matsui, T; Niwa, H; Ozawa, Y; Suda, T; Tanahashi, M; Yamada, K; Yokomura, K | 1 |
1 other study(ies) available for docetaxel anhydrous and Chronic Lung Injury
Article | Year |
---|---|
Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Drug Combinations; Female; Humans; Logistic Models; Lung Diseases, Interstitial; Lung Injury; Lung Neoplasms; Male; Medical Records; Middle Aged; Oxonic Acid; Predictive Value of Tests; Retrospective Studies; Risk; Taxoids; Tegafur; Tomography, X-Ray Computed | 2016 |